{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:38:01Z","timestamp":1792787881392,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T00:00:00Z","timestamp":1766707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":33,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Merck Sharp & Dohme (Asia) Investigator Studies Program"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pre-exposure prophylaxis (PrEP) has changed the paradigm of HIV prevention. A majority of men who have sex with men (MSM) were using oral tablets; meanwhile alternative long-acting modalities have been and are being developed. We aimed to assess the prevalence of PrEP use and the preferences of potential long-acting PrEP in the MSM community in Hong Kong, an Asian Pacific city where free or subsidised PrEP is not available.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A cross-sectional study was conducted using an online self-administered questionnaire. Eligible participants were adult MSM without HIV infection who normally resided in Hong Kong. Historical and current PrEP use, and preferences of using long-acting injectable for PrEP were tested against sociodemographic and sexual behavioural factors using chi-squared test and multivariable logistic regression model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of the 437 responses collected, 17% had ever used PrEP and 16% were currently using PrEP. Current PrEP users were more likely to have a higher income level (adjusted odds ratio [aOR] 2.11,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.04), have engaged in chemsex (aOR 4.02,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.01), have a non-regular male sex partner (aOR 2.66,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.02), have a male sex partner living with HIV (aOR 3.60,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.01), and be inclined to have condomless sex in the future (aOR 6.86,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.01). Among ever users, MSM who discontinued PrEP had a lower sexual risk than current users, such as recent history of chemsex (OR 0.22,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.01) and inclination to have condomless sex (OR 0.15,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.01). Long-acting injectables were accepted by 27% MSM, who were more likely to be current PrEP users (odds ratio [OR] 2.35,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.01), concerned about efficacy (OR 1.66,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.03), and expecting to use PrEP for more than 2 years in the future (OR 9.69,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.01).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The higher prevalence of PrEP among MSM indicated an increased awareness over the past decade. However, its promotion could have been hindered by the absence of a publicly funded or subsidised programme. While PrEP users had a higher sexual risk, the utilisation pattern would be affected by the dynamicity of sexual activities. Long-acting injectables had a moderate acceptance rate. Current PrEP users and those anticipated long-term users could be prioritised for its promotion.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12889-025-26025-5","type":"journal-article","created":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T02:35:21Z","timestamp":1766716521000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Utilisation of HIV pre-exposure prophylaxis and preferences of alternative long-acting modalities among men who have sex with men in Hong kong: a cross-sectional study"],"prefix":"10.1186","volume":"26","author":[{"given":"Tsz Ho","family":"Kwan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise Pui Chung","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shui Shan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,26]]},"reference":[{"issue":"27","key":"26025_CR1","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","volume":"363","author":"RM Grant","year":"2010","unstructured":"Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, Goicochea P, Casap\u00eda M, Guanira-Carranza JV, Ramirez-Cardich ME, Montoya-Herrera O, Fern\u00e1ndez T, Veloso VG, Buchbinder SP, Chariyalertsak S, Schechter M, Bekker LG, Mayer KH, Kall\u00e1s EG, Amico KR, Mulligan K, Bushman LR, Hance RJ, Ganoza C, Defechereux P, Postle B, Wang F, McConnell JJ, Zheng JH, Lee J, Rooney JF, Jaffe HS, Martinez AI, Burns DN, Glidden DV. iPrEx study Team. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363(27):2587\u201399.","journal-title":"N Engl J Med"},{"issue":"1","key":"26025_CR2","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1080\/22221751.2020.1718554","volume":"9","author":"TH Kwan","year":"2020","unstructured":"Kwan TH, Wong NS, Lui GCY, Chan KCW, Tsang OTY, Leung WS, Ho KM, Lee MP, Lam W, Chan SN, Chan DPC, Lee SS. Incorporation of information diffusion model for enhancing analyses in HIV molecular surveillance. Emerg Microbes Infect. 2020;9(1):256\u201362.","journal-title":"Emerg Microbes Infect"},{"issue":"23","key":"26025_CR3","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1056\/NEJMoa1506273","volume":"373","author":"JM Molina","year":"2015","unstructured":"Molina JM, Capitant C, Spire B, Pialoux G, Cotte L, Charreau I, Tremblay C, Le Gall JM, Cua E, Pasquet A, Raffi F, Pintado C, Chidiac C, Chas J, Charbonneau P, Delaugerre C, Suzan-Monti M, Loze B, Fonsart J, Peytavin G, Cheret A, Timsit J, Girard G, Lorente N, Pr\u00e9au M, Rooney JF, Wainberg MA, Thompson D, Rozenbaum W, Dor\u00e9 V, Marchand L, Simon MC, Etien N, Aboulker JP, Meyer L, Delfraissy JF, ANRS IPERGAY Study Group. On-Demand preexposure prophylaxis in men at high risk for HIV-1 infection. N Engl J Med. 2015;373(23):2237\u201346.","journal-title":"N Engl J Med"},{"issue":"9","key":"26025_CR4","doi-asserted-by":"publisher","first-page":"e25795","DOI":"10.1002\/jia2.25795","volume":"24","author":"TH Kwan","year":"2021","unstructured":"Kwan TH, Lui GCY, Lam TTN, Lee KCK, Wong NS, Chan DPC, Lee SS. Comparison between daily and on-demand PrEP (pre-exposure prophylaxis) regimen in covering condomless anal intercourse for men who have sex with men in Hong kong: A randomized, controlled, open-label, crossover trial. J Int AIDS Soc. 2021;24(9):e25795.","journal-title":"J Int AIDS Soc"},{"issue":"4","key":"26025_CR5","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1007\/s10461-023-04167-0","volume":"28","author":"NS Wong","year":"2024","unstructured":"Wong NS, Chan DP, Kwan TH, Lui GC, Lee KC, Lee SS. Dynamicity of HIV Pre-exposure prophylaxis usage pattern and association with executed adherence in MSM: an implementation study in Hong Kong. AIDS Behav. 2024;28(4):1327\u201344.","journal-title":"AIDS Behav"},{"issue":"4","key":"26025_CR6","doi-asserted-by":"publisher","first-page":"281","DOI":"10.7326\/M19-3337","volume":"172","author":"DS Krakower","year":"2020","unstructured":"Krakower DS, Daskalakis DC, Feinberg J, Marcus JL. Tenofovir Alafenamide for HIV preexposure prophylaxis: what can we DISCOVER about its true value? Ann Intern Med. 2020;172(4):281\u20132.","journal-title":"Ann Intern Med"},{"issue":"4","key":"26025_CR7","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1089\/apc.2022.0198","volume":"37","author":"Y Huang","year":"2023","unstructured":"Huang Y, Tian R, Zhou Z, Xu J, Agins B, Zou H, Chen Q, Sun Z, Zhong Q, Ma Z, Jiang H. HIV Pre-Exposure prophylaxis use on a global scale among men who have sex with men: A systematic review and Meta-Analysis. AIDS Patient Care STDS. 2023;37(4):159\u201391.","journal-title":"AIDS Patient Care STDS"},{"issue":"6","key":"26025_CR8","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1097\/QAD.0000000000003494","volume":"37","author":"VA Fonner","year":"2023","unstructured":"Fonner VA, Ridgeway K, van der Straten A, Lorenzetti L, Dinh N, Rodolph M, Schaefer R, Schmidt HA, Nguyen VTT, Radebe M, Peralta H, Baggaley R. Safety and efficacy of long-acting injectable cabotegravir as preexposure prophylaxis to prevent HIV acquisition. AIDS. 2023;37(6):957\u201366.","journal-title":"AIDS"},{"issue":"12","key":"26025_CR9","doi-asserted-by":"publisher","first-page":"e767","DOI":"10.1016\/S2352-3018(23)00261-8","volume":"10","author":"RJ Landovitz","year":"2023","unstructured":"Landovitz RJ, Hanscom BS, Clement ME, Tran HV, Kallas EG, Magnus M, Sued O, Sanchez J, Scott H, Eron JJ, Del Rio C, Fields SD, Marzinke MA, Eshleman SH, Donnell D, Spinelli MA, Kofron RM, Berman R, Piwowar-Manning EM, Richardson PA, Sullivan PA, Lucas JP, Anderson PL, Hendrix CW, Adeyeye A, Rooney JF, Rinehart AR, Cohen MS, McCauley M, Grinsztejn B, HPTN 083 Study Team. Efficacy and safety of long-acting cabotegravir compared with daily oral Tenofovir disoproxil fumarate plus emtricitabine to prevent HIV infection in cisgender men and transgender women who have sex with men 1 year after study unblinding: a secondary analysis of the phase 2b and 3 HPTN 083 randomised controlled trial. Lancet HIV. 2023;10(12):e767\u201378.","journal-title":"Lancet HIV"},{"issue":"Suppl 2","key":"26025_CR10","doi-asserted-by":"publisher","first-page":"e26107","DOI":"10.1002\/jia2.26107","volume":"26","author":"L Lorenzetti","year":"2023","unstructured":"Lorenzetti L, Dinh N, van der Straten A, Fonner V, Ridgeway K, Rodolph M, Schaefer R, Schmidt HA, Baggaley R. Systematic review of the values and preferences regarding the use of injectable pre-exposure prophylaxis to prevent HIV acquisition. J Int AIDS Soc. 2023;26(Suppl 2):e26107.","journal-title":"J Int AIDS Soc"},{"issue":"10","key":"26025_CR11","doi-asserted-by":"publisher","first-page":"e0293297","DOI":"10.1371\/journal.pone.0293297","volume":"18","author":"J Fu","year":"2023","unstructured":"Fu J, Dai Z, Wang H, Si M, Chen X, Wu Y, Xiao W, Huang Y, Yu F, Mi G, Su X. Willingness to use long-acting injectable PrEP among HIV-negative\/unknown men who have sex with men in Mainland china: A cross-sectional online survey. PLoS ONE. 2023;18(10):e0293297.","journal-title":"PLoS ONE"},{"issue":"1","key":"26025_CR12","doi-asserted-by":"publisher","first-page":"5116","DOI":"10.1038\/s41598-023-32014-8","volume":"13","author":"SA John","year":"2023","unstructured":"John SA, Zapata JP, Dang M, Pleuhs B, O\u2019Neil A, Hirshfield S, Walsh JL, Petroll AE, Quinn KG. Exploring preferences and decision-making about long-acting injectable HIV pre-exposure prophylaxis (PrEP) among young sexual minority men 17\u201324 years old. Sci Rep. 2023;13(1):5116.","journal-title":"Sci Rep"},{"issue":"1","key":"26025_CR13","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1186\/s12889-023-16382-4","volume":"23","author":"BG Rogers","year":"2023","unstructured":"Rogers BG, Chan PA, Sutten-Coats C, Zanowick-Marr A, Patel RR, Mena L, Goedel WC, Chu C, Silva E, Galipeau D, Arnold T, Gomillia C, Curoe K, Villalobos J, Underwood A, Sosnowy C, Nunn AS. Perspectives on long-acting formulations of pre-exposure prophylaxis (PrEP) among men who have sex with men who are non-adherent to daily oral PrEP in the united States. BMC Public Health. 2023;23(1):1643.","journal-title":"BMC Public Health"},{"key":"26025_CR14","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1146\/annurev-med-090518-093731","volume":"71","author":"JM Baeten","year":"2020","unstructured":"Baeten JM, Hendrix CW, Hillier SL. Topical microbicides in HIV prevention: state of the promise. Annu Rev Med. 2020;71:361\u201377.","journal-title":"Annu Rev Med"},{"issue":"1","key":"26025_CR15","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1186\/s12879-020-05024-4","volume":"20","author":"Z Wang","year":"2020","unstructured":"Wang Z, Mo PKH, Ip M, Fang Y, Lau JTF. Uptake and willingness to use PrEP among Chinese gay, bisexual and other men who have sex with men with experience of sexualized drug use in the past year. BMC Infect Dis. 2020;20(1):299.","journal-title":"BMC Infect Dis"},{"issue":"4","key":"26025_CR16","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1177\/09564624211060824","volume":"33","author":"JYC Lau","year":"2022","unstructured":"Lau JYC, Wong NS, Lee KCK, Kwan TH, Lui GCY, Chan DPC, Lee SS. What makes an optimal delivery for PrEP against HIV: A qualitative study in MSM. Int J STD AIDS. 2022;33(4):322\u20139.","journal-title":"Int J STD AIDS"},{"issue":"4","key":"26025_CR17","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1007\/s10461-017-1978-0","volume":"22","author":"TH Kwan","year":"2018","unstructured":"Kwan TH, Lee SS. Predictors of HIV testing and their influence on PrEP acceptance in men who have sex with men: A Cross-Sectional study. AIDS Behav. 2018;22(4):1150\u20137.","journal-title":"AIDS Behav"},{"issue":"3","key":"26025_CR18","doi-asserted-by":"publisher","first-page":"e34","DOI":"10.2196\/jmir.6.3.e34","volume":"6","author":"G Eysenbach","year":"2004","unstructured":"Eysenbach G. Improving the quality of web surveys: the checklist for reporting results of internet E-Surveys (CHERRIES). J Med Internet Res. 2004;6(3):e34.","journal-title":"J Med Internet Res"},{"issue":"11","key":"26025_CR19","doi-asserted-by":"publisher","first-page":"e113791","DOI":"10.1371\/journal.pone.0113791","volume":"9","author":"KK Leung","year":"2014","unstructured":"Leung KK, Wong HT, Naftalin CM, Lee SS. A new perspective on sexual mixing among men who have sex with men by body image. PLoS ONE. 2014;9(11):e113791.","journal-title":"PLoS ONE"},{"issue":"2","key":"26025_CR20","doi-asserted-by":"publisher","first-page":"e0191671","DOI":"10.1371\/journal.pone.0191671","volume":"13","author":"Z Wang","year":"2018","unstructured":"Wang Z, Lau JTF, Fang Y, Ip M, Gross DL. Prevalence of actual uptake and willingness to use pre-exposure prophylaxis to prevent HIV acquisition among men who have sex with men in Hong Kong, China. PLoS ONE. 2018;13(2):e0191671.","journal-title":"PLoS ONE"},{"issue":"1","key":"26025_CR21","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1097\/QAI.0000000000001885","volume":"80","author":"J Milam","year":"2019","unstructured":"Milam J, Jain S, Dub\u00e9 MP, Daar ES, Sun X, Corado K, Ellorin E, Blumenthal J, Haubrich R, Moore DJ, Morris SR, CCTG Team. Sexual risk compensation in a Pre-exposure prophylaxis demonstration study among individuals at risk of HIV. J Acquir Immune Defic Syndr. 2019;80(1):e9\u201313.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"26025_CR22","doi-asserted-by":"publisher","first-page":"e13083","DOI":"10.2196\/13083","volume":"5","author":"TH Kwan","year":"2019","unstructured":"Kwan TH, Lee SS. Bridging awareness and acceptance of Pre-Exposure prophylaxis among men who have sex with men and the need for targeting chemsex and HIV testing: Cross-Sectional survey. JMIR Public Health Surveill. 2019;5(3):e13083.","journal-title":"JMIR Public Health Surveill"},{"issue":"14","key":"26025_CR23","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1001\/jama.2019.2947","volume":"321","author":"MW Traeger","year":"2019","unstructured":"Traeger MW, Cornelisse VJ, Asselin J, Price B, Roth NJ, Willcox J, Tee BK, Fairley CK, Chang CC, Armishaw J, Vujovic O, Penn M, Cundill P, Forgan-Smith G, Gall J, Pickett C, Lal L, Mak A, Spelman TD, Nguyen L, Murphy DA, Ryan KE, El-Hayek C, West M, Ruth S, Batrouney C, Lockwood JT, Hoy JF, Hellard ME, Stoov\u00e9 MA, Wright EJ, PrEPX Study Team. Association of HIV preexposure prophylaxis with incidence of sexually transmitted infections among individuals at high risk of HIV infection. JAMA. 2019;321(14):1380\u201390.","journal-title":"JAMA"},{"issue":"17\u201318","key":"26025_CR24","doi-asserted-by":"publisher","first-page":"3254","DOI":"10.1111\/jocn.13990","volume":"27","author":"K Freeborn","year":"2018","unstructured":"Freeborn K, Portillo CJ. Does pre-exposure prophylaxis for HIV prevention in men who have sex with men change risk behaviour? A systematic review. J Clin Nurs. 2018;27(17\u201318):3254\u201365.","journal-title":"J Clin Nurs"},{"issue":"2","key":"26025_CR25","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1080\/09540121.2017.1360992","volume":"30","author":"EF Closson","year":"2018","unstructured":"Closson EF, Mitty JA, Malone J, Mayer KH, Mimiaga MJ. Exploring strategies for PrEP adherence and dosing preferences in the context of sexualized recreational drug use among MSM: a qualitative study. AIDS Care. 2018;30(2):191\u20138.","journal-title":"AIDS Care"},{"issue":"1","key":"26025_CR26","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1186\/s12889-022-14279-2","volume":"22","author":"PA Shuper","year":"2022","unstructured":"Shuper PA, Varatharajan T, Kinitz DJ, Gesink D, Joharchi N, Bogoch II, Loutfy M, Rehm J. Perceived influence of alcohol consumption, substance use, and mental health on PrEP adherence and condom use among PrEP-prescribed gay, bisexual, and other men-who-have-sex-with-men: a qualitative investigation. BMC Public Health. 2022;22(1):1875.","journal-title":"BMC Public Health"},{"key":"26025_CR27","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.drugpo.2019.10.007","volume":"74","author":"C O\u2019Halloran","year":"2019","unstructured":"O\u2019Halloran C, Rice B, White E, Desai M, Dunn DT, McCormack S, Sullivan AK, White D, McOwan A, Gafos M. Chemsex is not a barrier to self-reported daily PrEP adherence among PROUD study participants. Int J Drug Policy. 2019;74:246\u201354.","journal-title":"Int J Drug Policy"},{"issue":"4","key":"26025_CR28","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1007\/s10461-017-1871-x","volume":"22","author":"K Meyers","year":"2018","unstructured":"Meyers K, Rodriguez K, Brill AL, Wu Y, La Mar M, Dunbar D, Koblin B, Margolis D, Sobieszczyk ME, Van Tieu H, Frank I, Markowitz M, Golub SA. Lessons for patient education around Long-Acting injectable prep: findings from a Mixed-Method study of phase II trial participants. AIDS Behav. 2018;22(4):1209\u201316.","journal-title":"AIDS Behav"},{"issue":"11","key":"26025_CR29","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1089\/apc.2019.0093","volume":"33","author":"J Ellison","year":"2019","unstructured":"Ellison J, van den Berg JJ, Montgomery MC, Tao J, Pashankar R, Mimiaga MJ, Chan PA. Next-Generation HIV Pre-Exposure prophylaxis preferences among men who have sex with men taking daily oral Pre-Exposure prophylaxis. AIDS Patient Care STDS. 2019;33(11):482\u201391.","journal-title":"AIDS Patient Care STDS"},{"issue":"8","key":"26025_CR30","doi-asserted-by":"publisher","first-page":"e70025","DOI":"10.1002\/jia2.70025","volume":"28","author":"W Tieosapjaroen","year":"2025","unstructured":"Tieosapjaroen W, Bavinton BR, Schmidt HA, Chan C, Green KE, Phanuphak N, Poonkasetwattana M, Suwandi NS, Fraser D, Boonyapisomparn H, Cassell M, Zhang L, Tang W, Ong JJ. Preferences for HIV pre-exposure prophylaxis among men who have sex with men and trans women in 15 countries and territories in Asia and australia: a discrete choice experiment. J Int AIDS Soc. 2025;28(8):e70025.","journal-title":"J Int AIDS Soc"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-025-26025-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-26025-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-26025-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T11:40:53Z","timestamp":1769600453000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12889-025-26025-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,26]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["26025"],"URL":"https:\/\/doi.org\/10.1186\/s12889-025-26025-5","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,26]]},"assertion":[{"value":"14 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by The Chinese University of Hong Kong Survey and Behavioural Research Ethics Committee (Ref. No. SBRE-21-0470). All participants gave online informed consent before participation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"THK is an Editorial Board Member of BMC Public Health. We declare no other competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"361"}}